Xuezhikang Capsule
Shop NowOverview
What is Xuezhikang Capsule?
Xuezhikang Capsule is a single-ingredient proprietary Traditional Chinese Medicine (TCM) preparation made from red yeast rice, primarily used to manage hyperlipidemia and abnormal blood lipid levels.
Product Information
| Chinese name | 血脂康胶囊 |
|---|---|
| Alternative Name | Xuezhikang Jiaonang |
| Brand | WBL |
| Manufacturer | Peking University WBL Biotech Co., Ltd. |
| China Drug Approval No. | Z10950029 |
| Dosage form | capsule |
| Strength | 0.3 g per capsule |
| Individual package | 0.3g*24 capsules |
| GTIN | 6919959180241 |
| Prescription Status in China | Prescription medicine. |
Benefits & Uses
Benefits & Common Uses
Xuezhikang Capsule is labeled for:
- Hyperlipidemia
- High cholesterol and abnormal blood lipid levels
- Adjunctive management of cardiovascular and cerebrovascular conditions associated with hyperlipidemia and atherosclerosis
Traditional Functions & Uses
化浊降脂，活血化瘀，健脾消食
Resolve turbidity and lower lipids, promote blood circulation and support digestion.
- Hyperlipidemia within the labeled traditional presentation.
- Adjunctive treatment for other cardio-cerebrovascular disease associated with hyperlipidemia and atherosclerosis.
Traditional pattern terminology is not a biomedical diagnosis and should not be used for self-diagnosis.
Xuezhikang Capsule is classified as a prescription medicine in China. This Learn information is for educational purposes only. Always consult a healthcare provider before starting TCM treatments.
Safety
Adverse Reactions
- Gastrointestinal discomfort
- Possible elevation of aminotransferases or creatine kinase
Contraindications
- Do not use with active hepatitis or unexplained elevated serum aminotransferases.
Precautions
Pregnant or breastfeeding people should seek medical advice before use.
Discuss other medicines with a physician or pharmacist because interactions may occur.
Evidence
Evidence at a Glance
Human studies include randomized trials in secondary prevention, dyslipidemia and coronary heart disease, with important population and duration limits.
Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction
The study reported fewer coronary events with Xuezhikang than placebo in Chinese patients with previous myocardial infarction.
View More
Sample size: 4,870
Duration: Mean 4.5 years
Reported findings
The study reported fewer coronary events with Xuezhikang than placebo in Chinese patients with previous myocardial infarction.
Interpretation
This evidence applies to the studied population and regimen.
Limitations
The population was specific to secondary prevention after myocardial infarction.
Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. 2008.
Study type: Randomized placebo-controlled secondary-prevention trial
PMID: 18549841
Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study
Both tested Xuezhikang doses lowered non-HDL-C and LDL-C versus placebo in the study abstract.
View More
Sample size: 116
Duration: 12 weeks
Reported findings
Both tested Xuezhikang doses lowered non-HDL-C and LDL-C versus placebo in the study abstract.
Interpretation
This evidence applies to the studied population and regimen.
Limitations
Short duration and selected population limit generalization.
Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study. 2014.
Study type: Multicenter randomized placebo-controlled trial
PMID: 25499939
Comparison of the Reductions in LDL-C and Non-HDL-C Induced by the Red Yeast Rice Extract Xuezhikang Between Fasting and Non-fasting States in Patients With Coronary Heart Disease
The small study reported lower LDL-C and non-HDL-C after six weeks with Xuezhikang.
View More
Sample size: 50
Duration: 6 weeks
Reported findings
The small study reported lower LDL-C and non-HDL-C after six weeks with Xuezhikang.
Interpretation
This evidence applies to the studied population and regimen.
Limitations
Small, short study in selected patients with coronary heart disease.
Comparison of the Reductions in LDL-C and Non-HDL-C Induced by the Red Yeast Rice Extract Xuezhikang Between Fasting and Non-fasting States in Patients With Coronary Heart Disease. 2021.
Study type: Randomized placebo-controlled trial
PMID: 34434972
Verification
- Brand relationship confirmed
- Manufacturer legal name confirmed
- Approval number confirmed
- Current packaging matched
- Registration holder / manufacturer checked
- Authenticity method checked
- Label/source evidence recorded
Official Label Dosage
Take 2 capsules orally twice daily after meal
A purchase option’s quantity does not define how long you should take the medicine.